Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course

e-pub ahead of print date: 7 December 2022

Published date: February 2023

Additional Information: Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: SC declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health, Canadian ADHD Alliance Resource, British Association of Pharmacology and from Healthcare Convention for educational activity on ADHD. He is supported by National Institute for Health and Care Research. DN is supported by the National Institute for Health Research under the Applied Health Research programme for Northwest London. CH is supported by a NIHR Senior Investigator Award. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. CM has participated in research, teaching or consultancy activities unrelated to the current work with Angelini, Esteve, Exeltis, Janssen, Lundbeck, Neuraxpharm, Nuvelution, Otsuka, Pfizer, Servier and Sunovion. All authors received honoraria from the British Association of Pharmacology for educational activity. The other authors declare no relevant conflicts of interest.

Keywords: Adolescent, Child, Humans, Mental Disorders/drug therapy, Psychopharmacology, Psychotropic Drugs/therapeutic use

Local EPrints ID: 477192

URI: http://eprints.soton.ac.uk/id/eprint/477192

DOI: doi:10.1177/02698811221140005

ISSN: 0269-8811

PURE UUID: 1cc4040e-2d06-4e3a-9fed-e75818e1284d

ORCID for Samuele Cortese: orcid.org/0000-0001-5877-8075

Date deposited: 01 Jun 2023 16:31

Last modified: 17 Mar 2024 03:37